ADMA - Giving ADMA Biologics A Well-Deserved 'Booyah'

2024-05-12 06:00:07 ET

Summary

• ADMA Biologics reported stellar Q1 results after the bell on Thursday, May 9th, and the stock shot forward by 27% in trading on Friday.
• The company seems to be executing on all cylinders, and management ratcheted up forward guidance for both FY2024 and FY2025.
• Can the shares continue to rally after this 'Booyah' quarter? An updated analysis around ADMA Biologics follows in the paragraphs below.

ADMA Biologics ( ADMA ) reported Q1 results after the bell on Thursday. The company posted stellar results and raised forward guidance. Shareholders were rewarded with a better than 25% rally in the stock on Friday. Can the good times continue? We take a look at the quarterly results and update our investment thesis on ADMA Biologics below....

For further details see: